NEUROD1 and small cell lung carcinoma: (16) proposed to classify SCLC into four subtypes, A, N, Y, and P, based on four transcription factors (ASCL1, NeuroD1, YAP1, and POU2F3), advancing the development of precision therapy for SCLC.